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According to the World Health Organization, an unhealthy diet and insufficient physical
activity are the leading global risks to health. Dietary behavior is a modifiable factor
in cardiovascular disease (CVD) prevention. Furthermore, the fact that cardiovascular
events and stress-related emotional disorders share a common epidemiology may
indicate the existence of pathways linking these two diseases (Chauvet-Gelinier and
Bonin, 2017). Psychosocial stress can lead to changes in dietary patterns (DP) and
under chronic stress conditions, high caloric and hyperpalatable foods are preferred.
The interplay between these two factors impacts on several biological pathways: for
example, it can prime the hippocampus to produce a potentiated neuroinflammatory
response, generating memory deficits; it can also affect gut microbiota composition,
ultimately influencing behavior and brain health and creating a predisposition to the
development of diseases such as obesity, CVD, diabetes and metabolic syndrome.
Though both cognition and emotion can be heavily affected by caloric intake, diet
composition and stress, the molecular pathways involved remain elusive (Spencer et al.,
2017). In this review, we describe the interplay between stress and DP at a molecular
level, and how these factors relate to brain health and mental fitness. Finally, we show
how these findings could give rise to novel therapeutic targets for chronic diseases.
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INTRODUCTION
Cardiovascular disease (CVD), is the leading cause of mortality and disability worldwide.
According to the Global Burden of Disease study, ischemic heart disease and stroke accounted
for 25% of total deaths worldwide in 2013 (Rubinstein et al., 2010; GBD 2013 Mortality and Causes
of Death Collaborators, 2015).
The current epidemic of CVD is largely explained by several modifiable risk factors associated
with lifestyle, feasible to modify. In this sense, an unbalanced diet, excessive alcohol and
tobacco consumption, hypercholesterolemia, diabetes mellitus, high blood pressure, visceral
obesity, physical inactivity and psychosocial stress increase the risk of future CVD events
and are responsible for an estimated 90% of the population-attributable risk fraction of
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FIGURE 1 | Relationship between nutritional changes and emotional state and brain health.
ischemic heart disease and stroke worldwide (Schächinger et al.,
2000; O’Donnell et al., 2010; Uthman et al., 2014; Karmali
et al., 2017). Even more stress-related psychological disorders
such as depression show a higher prevalence in patients
with coronary artery disease or heart failure compared with
the general population (Lane et al., 2002; Ruo et al., 2003;
Rutledge et al., 2006).
Chronic or acute exposure to stress (defined as an ongoing
or anticipated threat to homeostasis or well-being) favors to the
destabilization of the dynamic balance of the organism, and its
response promotes the release of chemical mediators that affect
the metabolic and behavioral state in humans. Stress-induced
activation of the neuroendocrine hypothalamic-pituitary-adrenal
axis (HPA), upon exposure to a stressor cortisol is expected to
exert widespread metabolic effects, which is mostly necessary to
maintain or restore homeostasis. Stress, perhaps, is the trigger in
the cascade of neuroendocrine effects that drive the development
of the visceral distribution of adipose tissue, resistance to
insulin and the consequent hyperinsulinemia, thus leading to
the accumulation of cardiovascular risk factors (Serrano Ríos,
2005). Since glucocorticoids favor increased adiposity, mainly,
abdominal fat, they can lead to increased appetite, affecting the
quantity and quality of the diet (increased sweet and high fat
food intake), and body weight gain. Thus, exposure to stress can
modify eating behavior. These stress-induced alterations in food
intake and energy balance then interacting with emotional state
and health cardiovascular, Figure 1 (Epel et al., 2001; Groesz
et al., 2012). Though a relationship between nutritional changes
and emotional state and brain health is already known to exist,
the exact nature of this relationship has not been established.
Research over the last decade has focused on bidirectional
communication between gut and brain, termed the gut-brain
axis. Dysbiosis and inflammation of the gut have been linked
to several mental illnesses including anxiety and depression,
although the molecular pathways involved have not yet been
elucidated (Clapp et al., 2017).
The aim of this mini-review is to summarize the findings in
the literature on how stress influences the molecular pathways
affecting behavior, dietary patterns (DP) and their impact on
health, and the synergistic effects of this cycle.
Figure 1 The potential biological mechanisms that connect
the observed relationships between DP, stress and mental health
could be modulated by the immune and endocrine systems, brain
plasticity and the microbiome-gut-brain axis, being key targets
for nutritional therapy in future research.
METHODS
The authors conducted a literature search of available sources
describing issues relating to stress, DP and behavior. Research
studies were selected based on research topics found in globally
acknowledged databases such as Web of Science, PubMed,
Springer, and Scopus, from 2010 up to the present time and
classified according to their relevancy. The information provided
in the selected studies was carefully evaluated and is described
and discussed in the following sections.
NUTRITION AND CARDIOVASCULAR
DISEASE
Diet is one of the most studied factors in the pathogenesis of
CVD since it affects diverse cardiometabolic risk factors such
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as obesity, lipid blood profile, blood pressure, glucose-insulin
homeostasis, endothelial health, adipocyte metabolism, cardiac
function, metabolic expenditure, weight regulation, visceral
adiposity, and the microbiome (Mozaffarian, 2016).
Dietary patterns refers to the habitual combinations of foods
and meals consumed on a daily basis (Hu, 2002). Several
DP have been related to beneficial cardiovascular effects. For
example, the Mediterranean DP -characterized by moderate
energy intake, high consumption of olive oil, fish, legumes, nuts,
fruits, and vegetables; fewer red meats and processed (sodium-
preserved) meats; and a regular and moderate consumption of
red wine- is associated with low CVD incidence and mortality
(Shen et al., 2015; Sanches Machado d’Almeida et al., 2018).
This DP and others such as Prudent, DASH or Healthy DP
are high in fiber, vitamins, antioxidants, minerals, phenolics,
and unsaturated fats, and low in glycemic index, glycemic
load, salt, and trans fat (Esmaillzadeh et al., 2007; Mozaffarian
et al., 2011). The Western DP on the other hand, characterized
by a high intake of red meats, fat dairy products, refined
grains and sugars, has been positively correlated with higher
concentrations of markers of endothelial dysfunction, the first
step in CVD: fasting insulin, C peptide, leptin, C reactive
protein, homocysteine, tissue plasminogen activator antigen,
interleukin 6 (IL-6), E-selectin, intercellular adhesion molecule
1 (sICAM-1) and vascular cells of molecular adhesion 1
(sVCAM-1) (Defagó et al., 2014; Rodríguez-Monforte et al., 2015;
Marchiori et al., 2017).
In the long term, not only the quality but also the quantity
of nutrients consumed can influence the neural circuits
that regulate motivation, emotion and mood. Evidence
can be found in literature about the relationship between
saturated, trans fat intake and the risk of mental disorders
(Barnard et al., 2014). Chronic exposure to a high-fat diet
may affect the underlying neurobiological pathways of
emotion and reward via its action on energy metabolism,
endocrine function and immunity. Saturated and trans fatty
acids favor central fat deposition and have been related
with cardiometabolic and neurological diseases (Micha and
Mozaffarian, 2008). The omega-3 polyunsaturated fatty
acids (PUFAs) participate in modulation inflammation and
immunospecific response, cell growth and tissue repair.
Omega-3 plays a role in neuronal membrane fluidity and
receptor function and lower levels of these PUFAs have been
associated with common mental disorders such as depression
and generalized anxiety, also with accelerated neurodegeneration
(Grant and Guest, 2016).
Acute stress exposure (short term exposure) may shut
down appetite by corticotropin-releasing hormone action
and epinephrine liberation. However, if the stressor agent
persists, the increased cortisol increases appetite and the
motivation to eat (Razzoli et al., 2017). Experimental studies
have demonstrated how chronic stress exposure increases
susceptibility to diet-induced obesity, with induced spontaneous
binging and hyperphagia and a preference for highly-palatable
food, rich in calories, trans fat, salt and sugar (Packard et al.,
2014; Ulrich-Lai et al., 2015). Research on human behavior
shows a strong link between exposure to stress and binge eating
disorder, often associated with development the overweight and
obesity. Stress-induced non-nutritive food selection, is often
referred to as eating “comfort food” or highly palatable food
(Leigh et al., 2018).
NUTRITION, MICROBIOME AND
CARDIOVASCULAR DISEASE
The human gut microbiome contains 1014 resident micro-
organisms, among which bacteria are the most well-studied
group, predominated by gram positive Firmicutes and gram
negative Bacteroidetes (Cresci and Bawden, 2015). The collective
genome of the microbiome contains millions of genes compared
to the approximately 25,000 genes of the human genome and
thus contributes to a wide range of biochemical and metabolic
functions, such as nutrient acquisition, the harvesting of energy
and large numbers of host metabolic pathways.
Inflammatory related diseases has been related to intestinal
microbiome composition (bowel and skin diseases, autoimmune
arthritis, type 2 diabetes, and atherosclerosis among others)
(Buford, 2017). Specifically, an abnormal change in gut flora
has been linked to a range of CVD risk factors, including
obesity and diabetes. The first analyses on human intestinal
microbiota reported a lower amount of Bacteroidetes than
Firmicutes in obese individuals, however, these findings have not
been consistently demonstrated in all subsequent metagenomic
studies on obesity in humans (Ley, 2010). A lower abundance
of butyrate-producing bacteria, in particular Faecalibacterium
prausnitzii, a major member of the Firmicutes phylum, in
individuals with obesity-related metabolic disturbances and
diabetes has been observed. Furthermore, the presence of this
bacterium is inversely correlated with the intake of dietary
fat. Other studies have identified increased abundance of
Bifidobacteria species in healthy individuals compared with
individuals with obesity and diabetes (Martín et al., 2017).
Dysbiosis has also been linked to CVD and metabolic diseases
such as a lower ratio of Bacteroidetes to Firmicutes in obesity
and hypertension, or increased Collinsella in atherosclerosis
(Brahe et al., 2016).
Several DP have been studied for their ability to modulate
the intestinal microbiota. In general terms, a Western DP
led to a marked decrease in numbers of total bacteria and
beneficial Bifidobacterium and Eubacterium species, whereas
Mediterranean and Prudent DP have been linked to increases
in Lactobacillus, Bifidobacterium, and Prevotella, and decreases
in Clostridium (Koloverou et al., 2016; Singh et al., 2017).
However, dietary manipulation to modify gut microbiome is
still at the incipient stage It has been detected that dietary fiber
including prebiotics has a beneficial effect on gut microbiota
and host health, improving insulin sensitivity, low-grade chronic
inflammation, and lipid metabolism (Ahmadmehrabi and Tang,
2017). Prebiotics are non-digestible dietary compounds that
stimulate growth or activity of autochthonous microorganisms,
resulting in health benefits. They are basically oligo- or
polysaccharides of fructose or galactose and also lactulose and
lactitol; they promote the development of bifidobacteria, which
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are capable of degrading various complex carbohydrates. Many
Firmicutes and in particular Bacteroides are also able to carry out
this function (Suárez, 2013). Prebiotics are naturally present in
foods such as wheat, garlic, onion, asparagus, leek, beet, chicory
root, and artichoke, among others; they can also be added to
products such as milk, yogurt and breakfast cereals. In this regard,
adherence to a DP rich in fruits, vegetables and whole grains
may modulate the gut microbiome and thus favorably impact
on human health.
GUT BRAIN AXIS AND STRESS
The mechanisms underlying microbiota-gut-brain axis comm-
unication involves neuro-immune-endocrine mediators. This
interconnected network includes the central nervous system
(CNS), the autonomic nervous system, the enteric nervous
system and the HPA (Farzi et al., 2018).
In an organism exposed to stress, the hypothalamus
stimulates the pituitary by releasing corticotropin-releasing
factor (CRF). In the anterior pituitary, CRF causes the
release of the adrenocorticotropic hormone (ACTH), which
in turn stimulates the adrenals to cause an increased rate
of synthesis and release of cortisol (cortisol in humans and
corticosterone in rodents) (Foster et al., 2017). Cortisol serves to
maintain homeostasis during normal states of activity (regulating
cellular function and metabolism) and during periods of stress
(Christiansen et al., 2007).
Chronically elevated cortisol levels can disturb brain function,
affecting cognition, emotion and motivation, short and long-
term memory; sustained HPA axis activation also impairs the
immune system response, as has been demonstrated particularly
in early life stress (Shirtcliff et al., 2009). Cortisol exerts it’s effects
trough the interaction with two corticoid receptors, high affinity
mineralocorticoid receptors (MR) and low affinity glucocorticoid
receptors (GR). A persistently activated HPA axis will eventually
lead to a compensatory downregulation of the expression of GR
signaling through epigenetic modifications (Weaver et al., 2004).
In addition, glucocorticoids increase intestinal permeability, and
negatively affects the gut microbiota composition.
Stress-related changes could be also mediated by
neuroendocrine hormones, such as norepinephrine (NE)
and dopamine (DA); it has long been known that these
catecholamines can increase the growth rate of Gram-negative
bacteria (Lyte and Ernst, 1992).
In turn, changes in gut microbiome composition has been
already related to cognitive disorders and mental illness. There
is strong evidence linking major depression and microbiome,
and preclinical evidence related to anxiety disorders (Foster and
McVey Neufeld, 2013; Malan-Muller et al., 2017).
LINKING MICROBIOME AND NEURONAL
SIGNALING: MECHANISTIC EVIDENCE
Further research is required to elucidate the exact mechanisms
and mediators involved in brain-microbiota communication.
A central issue that remains unresolved is which mediators the
microbiota uses to communicate with the brain and how this
network ultimately influences behavior and health.
There are three major systems along with their mediators
playing a role in inter-talk between the microbiota and the brain:
neuronal communication, endocrine signaling mediators and
the immune system mediators. Together, these systems create
an integrated molecular network that impact both in gut and
brain function.
The gut communicates with the brain through a systemic,
central route. The vagus nerve sends information to the brain,
where it is processed in the nucleus tractus solitarius; this nucleus
then projects to the parabrachial nucleus, which in turns projects
to the prefrontal cortex (PFC) and amygdala. These latter are key
loci that control anxiety and fear responses. It has been reported
that both regions display irregularities in germ free animals (GF),
including hypermyelination in the PFC.
Previous papers have shown that the N-methyl-D-aspartate
(NMDA) receptor subunit (NMDArec2B) has reduced
expression in the amygdala of GF animals (Neufeld et al., 2011).
Furthermore, it has been demonstrated that feeding prebiotics to
these animals elevates their levels of brain-derived neurotrophic
factor (BDNF), NMDA receptor subunits, and D-serine in the
brain. Moreover, GABA receptor and serotonin 1A receptor are
upregulated in the amygdala and hippocampus, respectively,
upon supplementing GF animals with a Lactobacillus strain,
ultimately regulating behavior in mice (Bravo et al., 2011).
TABLE 1 | Molecular signaling pathways linking the microbiome with stress-related health outcomes.
Pathway Mediator Microbiome Health outcome References
Neural pathways Serotonin GF vs. specific pathogen-free animals (SPF) Anxiety-like behavior Neufeld et al., 2011; Clarke et al., 2012
GABA Bacteroides, Parabacteroides and
Escherichia species
Depression Strandwitz et al., 2018
miRNA GF vs. GF colonized animals Anxiety- and fear-related behavior Hoban et al., 2017
c-FOS Campylobacter jejuni Anxiety-like behavior Lyte et al., 2006; Goehler et al., 2008
BDNF GF animals Brain development Diaz Heijtz et al., 2011
Endocrine pathways Cortisol Lactobacillus helveticus, Bifidobacteria Anxiety-like behavior Foster et al., 2017
Immune signaling TNF-α Lactobacillus plantarum PS128 Improved anxiety-like behavior Liu et al., 2016
IL-6 Lactobacillus Inflammation, overweight, obesity. Cooper et al., 2016
IL-1β Akkermansia spp. and Blautia spp. Depression Marc et al., 2014; Wong et al., 2016
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The biogenic amine Serotonin [5-hydroxytryptamine (5-HT)]
exerts its function in the brain and in the ENS. Most of
5-HT is synthetized by gut mucosal enterochromaffin cells and
ENS neurons. Peripherally, 5-HT is involved in gastrointestinal
function, smooth muscle contraction and relaxation, and in pain
perception. In the brain it is involved in regulating mood and
cognition (Yano et al., 2015). Serotonin synthesis depends on the
availability of tryptophan, an essential amino acid that must be
supplied in the diet, and microbiota plays a central role in the
regulation and synthesis of this amine.
Together these findings reinforce the concept that DP can have
either a positive or a negative impact on the CNS by regulating
critical neurotransmitters implicated in psychiatric disorders,
such as depression (Wallace and Milev, 2017; Zalar et al., 2018).
Finally, the immune system plays an important intermediary
role between the brain and the gut. Gut-associated lymphoid
tissue is the main component of mucosal-associated lymphoid
tissue and corresponds to almost 70% of the entire immune
system (Vighi et al., 2008). Dysbiosis of the gut microbiota is
linked to abnormal immune responses, which are accompanied
by irregular cytokine synthesis and release. It has been
reported that TNFα and IFNγ production capacity appears
to be influenced by the microbiome, whereas cytokines such
as IL-1β, IL-6, and Th17-derived IL-17, and IL-22 display
fewer, but more specific, associations with the gut microbiota
(Schirmer et al., 2016).
Table 1 Mechanistic pathways, mediators and main
microbiome modifications associated with stress related
psychological disorders. Molecular signaling pathways linking
the microbiome with stress-related health outcomes.
Several studies related to preclinical models of bacterial
infections, probiotics treatment and analysis of germ-free (GF)
animals suggest that the microbiota can influence the CNS and
consequently behavior. Stress-related disorders such as anxiety
and depression are among the main psychiatric conditions
associated with microbiome changes (Desbonnet et al., 2010,
2015; Bravo et al., 2011).
CONCLUSION
The treatment of multidimensional diseases such as CVD
require multidimensional approaches. Nutritional psychiatry is
a growing field of research seeking to provide clinically relevant
interventions for multifactorial diseases. This emerging line of
inquiry has assembled data on biological pathways such as
gastrointestinal microbiota and inflammation, on DP and on how
these are modulated by the environment. It has become clear
that this intertwined network of environmental factors (such as
stress and DP) interacting with the above-mentioned pathways
combines to modulate behavior.
Some trending foods and (controversial) diets have
brought lasting changes to traditional diets, however, in
most cases neither these nor dietary supplements have
been subjected to adequate clinical trials to test their
safety and efficacy. A better understanding of the interplay
between diet, stress, neuronal signaling, phenotypes, and
the microbiome will provide important insights into the
utility of scientific evidence-based nutrition. Future studies
are imperative to proactively avoid cardiovascular events in
patient population.
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